Becton Dickinson EBITDA 2010-2024 | BDX

Becton Dickinson EBITDA for the quarter ending September 30, 2024 was $1.210B, a 29% increase year-over-year.

  • Becton Dickinson 2024 EBITDA was 4.684B, a 6.48% increase from 2023.
  • Becton Dickinson 2023 EBITDA was 4.399B, a 2.5% decline from 2022.
  • Becton Dickinson 2022 EBITDA was 4.512B, a 0.69% increase from 2021.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.

Becton Dickinson EBITDA 2010-2024 | BDX

  • Becton Dickinson 2024 EBITDA was 4.684B, a 6.48% increase from 2023.
  • Becton Dickinson 2023 EBITDA was 4.399B, a 2.5% decline from 2022.
  • Becton Dickinson 2022 EBITDA was 4.512B, a 0.69% increase from 2021.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company NameMarket
Cap
McKesson (MCK)$76.6B
Cardinal Health (CAH)$30.9B
West Pharmaceutical Services (WST)$24.6B
Straumann Holding AG (SAUHY)$23.1B
Labcorp (LH)$20.6B
Cooper (COO)$19.6B
Align Technology (ALGN)$16.8B
Henry Schein (HSIC)$10B
Merit Medical Systems (MMSI)$6.3B
DENTSPLY SIRONA (XRAY)$3.9B
Patterson (PDCO)$2.7B
CONMED (CNMD)$2.2B
STAAR Surgical (STAA)$1.2B
Lifevantage (LFVN)$274M
Pro-Dex (PDEX)$141M